20204.0CIBP

Overview of 2020CIBP Summit

Based on the transformation &upgrading and policy reform of China’s pharmaceutical industry, and theprevious successful experience of last session, China International Biopharma4.0 Summit(2020) will further deepen topics concerning the implementation of specific policies and regulations on the biological cell culture technology, protein characterization and optimization and ICH-Q series, and discuss more practical topics such as Pharma 4.0, the latest progress in technologies, future trends, digitization and intelligence of biopharma companies, CGMP quality management system from laboratories to plants, regulations on the use of SUS, optimization of cell culture technology, advanced experience of upstream and downstream biopharma technology, and outsourcing technology development IP. The summit will also provide an optimal platform for you to communicate with government officials, CMO, CRO, biopharma companies, pharmaceutical device providers, software and logistics solutions providers, industry leaders and experts on international projects.

了解更多

Introduction of some

Speakers

This summit provides a platform for participating representativesto have high-level dialogues. The representatives reached a cooperation intention on long-term projects on the site through in-depth exchange with high-level management of all enterprises and effective interaction between upstream and downstream industrial chain, which lent a splendid color to the summit. Most representatives were satisfied with the summit and expressed their expectation on the next session.